Cover Image
Read Now

Evidence brief: Barriers and facilitators to use of medications for opioid use disorder

The ESP Coordinating Center (ESP CC) is responding to a request from VA's Health Services Research and Development Service (HSR&D) for an evidence brief on barriers to and facilitators of use of buprenorphine and extended-release naltrexone for treatment of opioid use disorder (OUD). This r...

Full description

Bibliographic Details
Main Authors: Mackey, Katherine, Veazie, Stephanie (Author), Anderson, Johanna (Author), Bourne, Donald (Author)
Corporate Authors: United States Department of Veterans Affairs, VA Portland Health Care System Evidence Synthesis Program
Format: eBook
Language:English
Published: Washington, DC Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service August 2019, 2019
Series:Evidence synthesis program
Subjects:
Veterans Health
Opiate Substitution Treatment
Buprenorphine / Therapeutic Use
Opioid-related Disorders / Drug Therapy
Naltrexone / Therapeutic Use
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02134nam a2200349 u 4500
001 EB001999419
003 EBX01000000000000001162320
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
100 1 |a Mackey, Katherine 
245 0 0 |a Evidence brief: Barriers and facilitators to use of medications for opioid use disorder  |h Elektronische Ressource  |c Katherine Mackey, Stephanie Veazie, Johanna Anderson, Donald Bourne, Kim Peterson 
246 3 1 |a Barriers and facilitators to use of medications for opioid use disorder 
260 |a Washington, DC  |b Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service  |c August 2019, 2019 
300 |a 1 PDF file (iii, 37, i, 47 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Veterans Health 
653 |a Opiate Substitution Treatment 
653 |a Buprenorphine / therapeutic use 
653 |a Opioid-Related Disorders / drug therapy 
653 |a Naltrexone / therapeutic use 
700 1 |a Veazie, Stephanie  |e [author] 
700 1 |a Anderson, Johanna  |e [author] 
700 1 |a Bourne, Donald  |e [author] 
710 2 |a United States  |b Department of Veterans Affairs 
710 2 |a VA Portland Health Care System  |b Evidence Synthesis Program 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence synthesis program 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK549203  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a The ESP Coordinating Center (ESP CC) is responding to a request from VA's Health Services Research and Development Service (HSR&D) for an evidence brief on barriers to and facilitators of use of buprenorphine and extended-release naltrexone for treatment of opioid use disorder (OUD). This review synthesizes evidence on the barriers and facilitators at the patient, provider, and health care system levels. Findings from this review will be used to inform prioritization of questions for a September 2019 State-of-the-Art (SOTA) conference 

Similar Items